Circulating donor-specific anti-human leukocyte antigen antibodies and complement C4d deposition are associated with the development of cardiac allograft vasculopathy

scientific article published on 01 December 2014

Circulating donor-specific anti-human leukocyte antigen antibodies and complement C4d deposition are associated with the development of cardiac allograft vasculopathy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1309/AJCPTLBEU5BQ8SHN
P698PubMed publication ID25389335

P2093author name stringMalek Kamoun
Priti Lal
Renee Frank
Lee R Goldberg
Maria R Molina
Joyce W Wald
P433issue6
P407language of work or nameEnglishQ1860
P304page(s)809-815
P577publication date2014-12-01
P1433published inAmerican Journal of Clinical PathologyQ15750224
P1476titleCirculating donor-specific anti-human leukocyte antigen antibodies and complement C4d deposition are associated with the development of cardiac allograft vasculopathy
P478volume142

Reverse relations

cites work (P2860)
Q38839248Clinically relevant interpretation of solid phase assays for HLA antibody
Q38808100Innate immune mechanisms in transplant allograft vasculopathy
Q37352506Many de novo donor-specific antibodies recognize β2 -microglobulin-free, but not intact HLA heterodimers
Q38645385Potential Roles for C1 Inhibitor in Transplantation
Q39023584Recent advances in allograft vasculopathy.
Q37609092Significance of Anti-HLA Antibodies on Adult and Pediatric Heart Allograft Outcomes
Q47093542T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes
Q56963763The clinical impact of donor-specific antibodies in heart transplantation
Q26862195The perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejection
Q89148849Understanding the Correlation Between DSA, Complement Activation, and Antibody-Mediated Rejection in Heart Transplant Recipients

Search more.